Pharma-Bio Serv, Inc.

Equities

PBSV

US71711N1000

Business Support Services

Market Closed - OTC Markets 09:36:06 2024-04-18 am EDT 5-day change 1st Jan Change
0.8 USD +6.67% Intraday chart for Pharma-Bio Serv, Inc. -6.76% -23.81%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024 CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 CI
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Announces Special Dividend, Payable on or About April 14, 2023 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022 CI
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 15, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2021 CI
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About January 3, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Chart Pharma-Bio Serv, Inc.
More charts
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PBSV Stock
  4. News Pharma-Bio Serv, Inc.
  5. Insider Trends: 90-Day Insider Selling Trend Prolonged at Pharma-Bio Serv